BB536, a bifidobacterium longum strain, was then used to treat CKD rats; we found that BB536 could reduce IS levels in serum and heart tissue of CKD rats, and it reversed the decreased Kv4.2, Kv4.3, and KChIP2 proteins. Here, KCNIP2 is linked to chronic kidney disease.